Distinguishing hemangiomas from malignant solid hepatic lesions: A comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 2, 2011, Pages 310-317

  Ahn, Sung Jun ^a   Kim, Myeong Jin ^a   Hong, Hye Suk ^b   Ah Kim, Kyung ^c   Song, Ho Taek ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

gadoxetic acid disodium; heavily T2 weighted image; hemangioma; hepatic lesion; magnetic resonance imaging

Indexed keywords

GADOXETIC ACID;

ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL DIFFERENCE TO NOISE RATIO; SIGNAL NOISE RATIO;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 79960577314     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22658     Document Type: Article

References (20)

1. McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ,. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994; 193: 43-47. (Pubitemid 24297997)
2. Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG,. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 1997; 204: 729-737. (Pubitemid 27369033)
3. Chang SD, Thoeni RF,. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement. AJR Am J Roentgenol 2008; 190: 1318-1323. (Pubitemid 351684907)
4. Jeong YY, Mitchell DG, Holland GA,. Liver lesion conspicuity: T2-weighted breath-hold fast spin-echo MR imaging before and after gadolinium enhancement-initial experience. Radiology 2001; 219: 455-460. (Pubitemid 32336361)
5. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV,. Hepatobiliary- specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009; 29: 1725-1748.
6. Filippone A, Cianci R, Iezzi R, Legnini M, Storto ML,. Effect of clinical history in focal liver lesion detection and classification on 4-detector row computed tomography and gadoxetic acid enhanced MR imaging in oncologic patients. J Comput Assist Tomogr 2009; 33: 851-857.
7. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO,. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008; 43: 504-511.
8. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18: 457-467. (Pubitemid 351248177)
9. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-a multicenter trial. J Comput Assist Tomogr 2006; 30: 345-354. (Pubitemid 43922248)
10. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW,. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010; 20: 1052-1060.
11. Kim YK, Kwak HS, Kim CS, Han YM,. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009; 30: 437-443.
12. Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM,. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol 2009; 193: W490-496.
13. Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993; 189: 863-870. (Pubitemid 23354509)
14. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994; 192: 401-406.
15. Kim SH, Lee J, Kim MJ, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009; 192: 1675-1681.
16. Danet IM, Semelka RC, Leonardou P, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003; 181: 809-817. (Pubitemid 37021860)
17. Hanley JA, McNeil BJ,. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843. (Pubitemid 13033817)
18. Dwyer AJ,. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology 1991; 178: 328-330.
19. Lombardo DM, Baker ME, Spritzer CE, Blinder R, Meyers W, Herfkens RJ,. Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T. AJR Am J Roentgenol 1990; 155: 55-59. (Pubitemid 20218674)
20. Bennett GL, Petersein A, Mayo-Smith WW, Hahn PF, Schima W, Saini S,. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases. AJR Am J Roentgenol 2000; 174: 477-485. (Pubitemid 30067162)